# Effect of Weekly High-dose Vitamin D3 Supplementation on the Association Between Circulatory FGF-23 and A1c Levels

> **NCT04682626** · NA · COMPLETED · sponsor: **Applied Science Private University** · enrollment: 150 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2
- Kidney Diseases

## Interventions

- **DIETARY_SUPPLEMENT:** Soft gelatin capsules each contains 50 000 IU VD3 (cholecalciferol) equivalents to 1.25 mg.

## Key facts

- **NCT ID:** NCT04682626
- **Lead sponsor:** Applied Science Private University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-12-25
- **Primary completion:** 2021-03-05
- **Final completion:** 2021-03-20
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2022-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04682626

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04682626, "Effect of Weekly High-dose Vitamin D3 Supplementation on the Association Between Circulatory FGF-23 and A1c Levels". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04682626. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
